Neuromyelitis Optica Spectrum Disorder (NMOSD) Report

By www.marketscagr.com

Report Details

Report Name

Global And United State Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, Status And Forecast 2023-2027 Story

Pages

106

Price

$ 3900

Features

Neuromyelitis Optica Spectrum Disorder (NMOSD) Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              F. Hoffmann-La Roche Ltd
Alexion Pharmaceuticals
RemeGen
Nihon Pharmaceutical
Harbour BioMed
Lundbeck
Bionure
Opexa Therapeutics
TG Therapeutics
Bio-Thera Solutions
Boston Pharmaceuticals
Cour Pharmaceutical